Margaret A. Liu

Last updated

Margaret A. Liu (born June 11, 1956) [1] is a physician and researcher studying gene expression, immune responses, and vaccines. From 2015 to 2017, Liu served as president of the International Society of Vaccines. [2] She is currently a professor of microbiology and immunology at the University of California, San Francisco (UCSF) and a foreign adjunct professor at the Karolinska Institute in Stockholm, Sweden. [2] Since June 7, 2017, she has been a director of Ipsen S.A. in France. [3] [4]

Contents

She is a founder of the field of DNA-based vaccines, [5] [6] [7] [8] [9] and studies both plasmid DNA and mRNA vaccine technologies. [10] She was the first researcher to provide evidence that gene-based immunization could protect against infectious diseases such as influenza, tuberculosis, HPV, and HIV. In addition to her work with animal models, she was involved with the first trial of a gene-based influenza vaccine in humans. [6] In 2002, Discover magazine recognized Liu as one of the 50 most important women in science. [11]

Early life and education

Margaret's parents immigrated to the US from China for graduate school, and her mother moved her and her siblings to Durango, Colorado, after her father's death when Margaret was 4. They were one of the three Chinese families in the town. Growing up, Margaret's family struggled financially due to her father's death and racial prejudice making it hard for her mother to get jobs, despite her extensive education and qualifications. However, Margaret's childhood was a happy one, full of love from her mother and compassion for others. The support of her mother and the fairly diverse demographics of Durango inspired her to take risks in her career and life. She attended Durango High School, and also took advanced classes at Fort Lewis College starting at the age of 13. [12] Even early in her education, she showed promise: her teachers recall that they knew that she was "going places". [13] She graduated as Co-Valedictorian of the Class of 1973. She was a U.S. Presidential Scholar and received a Boettcher Scholarship, which fully funded her college degree. [14] She turned down acceptances to Yale University and Princeton University, in part because of the scholarship providing a full ride to a college in Colorado. [12]

She earned a B.A. in Chemistry, summa cum laude, at Colorado College. At Colorado College she discovered Biochemistry and Immunology, and also pursued her musical interests and played the flute for a woodwind quartet called the "Keytones" or the "Ketones". She completed her requirements and graduated a year early. She received a scholarship from the Rotary Foundation to study piano at a conservatory in Paris. [12] She earned a Diplome d'Enseignement in piano from the École Normale de Musique de Paris. [15]

She later obtained a Doctor of Medicine degree from Harvard Medical School. She completed her internship and residency training in internal medicine at Massachusetts General Hospital. She also completed a fellowship in endocrinology at Harvard. She became board certified in internal medicine and endocrinology and metabolism. [2] While at Massachusetts General Hospital, she met her future husband, Robert Johnson, whom she married in 1983. She decided to keep her last name for professional reasons and because she thought that her race would surprise people if her name was Margaret Johnson. [12]

Career

Her first position was as an instructor at Harvard, with funding from a 5-year Physician Scientist NIH grant. During this time she also worked at a visiting scientist at Massachusetts Institute of Technology with Herman Eisen.

In addition to her work at Harvard Medical School, Liu has been a visiting scientist at Massachusetts Institute of Technology, an adjunct Assistant Professor at the University of Pennsylvania, an adjunct professor at the University of California, San Francisco, and a visiting professor at Karolinska Institute in Stockholm. [2]

Liu has been the senior director of immunology at Merck Research Laboratories, West Point, Pennsylvania. [16] At Merck, she worked with Maurice Hilleman who was one of her most influential mentors. [12]

She has been a Vice President of vaccine research and gene therapy at Chiron Corporation, [15] [17] [18] a Vice-Chairman at Transgène, an independent director of Ipsen, [19] the president of the International Society for Vaccines from 2015 to 2017, [15] and the Executive Vice-Chair of the International Vaccine Institute. She was a senior advisor of vaccinology at the Bill & Melinda Gates Foundation, [2] [20] where she was responsible for "monitoring and enhancing…and in identifying new opportunities for investment" for their billion-dollar vaccine programs and investments. [21] During her time at the Gates Foundation, she worked part time at Transgène, realizing that she enjoyed splitting her time between organizations and jobs. [12] She served as a member of the U.S. National Advisory Allergy and Infectious Diseases (NIAID) Council [22] and was a member of the American Society of Clinical Investigation and a Fellow of the Molecular Medicine Society. [23]

Research

Liu develops novel approaches to vaccines and immune treatments for cancer. She pioneered the development of DNA vaccines, which may offer "the hope of better, more stable vaccines that can be rapidly produced." [11] [5] In response to the injection of DNA, the body may produce proteins that provoke an immune response, protecting against the virus. [16] [24] Some DNA vaccines are in clinical trials for humans. Others are already licensed for veterinary treatments. [25]

Awards and honors

See also

Related Research Articles

<span class="mw-page-title-main">DNA vaccine</span> Vaccine containing DNA

A DNA vaccine is a type of vaccine that transfects a specific antigen-coding DNA sequence into the cells of an organism as a mechanism to induce an immune response.

<span class="mw-page-title-main">David Baltimore</span> American biologist (born 1938)

David Baltimore is an American biologist, university administrator, and 1975 Nobel laureate in Physiology or Medicine. He is a professor of biology at the California Institute of Technology (Caltech), where he served as president from 1997 to 2006. He founded the Whitehead Institute and directed it from 1982 to 1990. In 2008, he served as president of the American Association for the Advancement of Science in 2008.

<span class="mw-page-title-main">Ellen Heber-Katz</span>

Ellen Heber-Katz is an American immunologist and regeneration biologist who is a professor at Lankenau Institute for Medical Research (LIMR). She discovered that the Murphy Roths Large (MRL) mouse strain can regenerate wounds without scarring, and can fully restore damaged tissues. Her work on regeneration has been extended into National Cancer Institute (NCI)-funded studies of novel aspects of breast cancer causation. Her research interests include immunology, regenerative medicine and cancer.

In immunology, an adjuvant is a substance that increases or modulates the immune response to a vaccine. The word "adjuvant" comes from the Latin word adiuvare, meaning to help or aid. "An immunologic adjuvant is defined as any substance that acts to accelerate, prolong, or enhance antigen-specific immune responses when used in combination with specific vaccine antigens."

Malaria vaccines are vaccines that prevent malaria, a mosquito-borne infectious disease which annually affects an estimated 247 million people worldwide and causes 619,000 deaths. The first approved vaccine for malaria is RTS,S, known by the brand name Mosquirix. As of April 2023, the vaccine has been given to 1.5 million children living in areas with moderate-to-high malaria transmission. It requires at least three doses in infants by age 2, and a fourth dose extends the protection for another 1–2 years. The vaccine reduces hospital admissions from severe malaria by around 30%.

The Grand Challenges in Global Health (GCGH) is a research initiative launched by the Bill & Melinda Gates Foundation in search of solutions to health problems in the developing world. Fifteen challenges are categorized in groups among seven stated goals plus an eighth group for family health. The disciplines involved include immunology, microbiology, genetics, molecular biology and cellular biology, entomology, agricultural sciences, clinical sciences, epidemiology, population and behavioral sciences, ecology, and evolutionary biology.

Barton Ford Haynes is an American physician and immunologist internationally recognized for work in T-cell immunology, retrovirology, and HIV vaccine development. Haynes is a Frederic M. Hanes Professor of Medicine and Immunology at Duke University Medical Center. He is the director of the Duke Human Vaccine Institute and the Duke Center for HIV/AIDS Vaccine Immunology and Immunogen Discovery (CHAVI-ID), which was funded by the National Institute of Allergy and Infectious Diseases (NIAID) in 2012. In addition, Haynes directs the B-cell Lineage Envelope Design Study, the Centralized Envelope Phase I Study, and the Role of IgA in HIV-1 Protection Study as part of the Collaboration for AIDS Vaccine Discovery (CAVD), which was funded by the Bill and Melinda Gates Foundation in 2006.

SAV001-H is the first candidate preventive HIV vaccine using a killed or "dead" version of the HIV-1 virus.

<span class="mw-page-title-main">Jennifer Gardy</span> Canadian biochemist

Jennifer Gardy is a Canadian scientist, educator and broadcaster, with expertise in the fields of molecular biology, biochemistry, and bioinformatics. Since February 2019 she has been the Deputy Director, Surveillance, Data, and Epidemiology on the Global Health: Malaria team at the Bill & Melinda Gates Foundation. She was previously an associate professor at the University of British Columbia's School of Population and Public Health, a Canada Research Chair in Public Health Genomics, and a Senior Scientist at the BC Centre for Disease Control. She is an occasional host of CBC's The Nature of Things, a science communicator, and a children's book author. She was elected to the National Academy of Medicine in 2021 as an International Member.

<span class="mw-page-title-main">Akiko Iwasaki</span> Immunobiologist

Akiko Iwasaki is a Sterling Professor of Immunobiology and Molecular, Cellular and Developmental Biology at Yale University. She is also a principal investigator at the Howard Hughes Medical Institute. Her research interests include innate immunity, autophagy, inflammasomes, sexually transmitted infections, herpes simplex virus, human papillomavirus, respiratory virus infections, influenza infection, T cell immunity, commensal bacteria, COVID-19 and Long COVID.

Katherine A. Fitzgerald is an Irish-born American molecular biologist and virologist. She is a professor of medicine currently working in the Division of Infectious Disease at the University of Massachusetts Medical School. She is also the director of the Program in Innate Immunity.

M. Juliana “Julie” McElrath is a senior vice president and director of the vaccine and infection disease division at Fred Hutchinson Cancer Research Center and the principal investigator of the HIV Vaccine Trials Network Laboratory Center in Seattle, Washington. She is also a professor at the University of Washington.

Dipyaman Ganguly is an Indian physician-scientist immunologist and cell biologist, currently a Principal Scientist and Swarnajayanthi Fellow at the CSIR-Indian Institute of Chemical Biology (IICB). He heads the Dendritic Cell Laboratory of IICB, popularly known as the Ganguly Lab, where he hosts several researchers involved in research on regulation of innate Immunity and pathogenesis of inflammatory disorders. The Council of Scientific and Industrial Research, the apex agency of the Government of India for scientific research, awarded him the Shanti Swarup Bhatnagar Prize for Science and Technology, one of the highest Indian science awards for his contributions to Medical Sciences in 2022.

Neoepitopes are a class of major histocompatibility complex (MHC) bounded peptides. They represent the antigenic determinants of neoantigens. Neoepitopes are recognized by the immune system as targets for T cells and can elicit immune response to cancer.

Dan Hung Barouch is an American physician, immunologist, and virologist. He is known for his work on the pathogenesis and immunology of viral infections and the development of vaccine strategies for global infectious diseases.

Pamela Sumiko Ohashi, PhD, FRSC is a Canadian medical researcher. She is co-director of the Campbell Family Institute for Breast Cancer Research, director of the Cancer Immune Therapy Program at the Princess Margaret Cancer Centre and a professor at the University of Toronto.

<span class="mw-page-title-main">Viral vector vaccine</span> Type of vaccine

A viral vector vaccine is a vaccine that uses a viral vector to deliver genetic material (DNA) that can be transcribed by the recipient's host cells as mRNA coding for a desired protein, or antigen, to elicit an immune response. As of April 2021, six viral vector vaccines, four COVID-19 vaccines and two Ebola vaccines, have been authorized for use in humans.

Penny M. Heaton is an American physician who is the Global Therapeutics Lead for Vaccines at Johnson & Johnson. She previously worked at Novavax, Novartis and the Bill & Melinda Gates Foundation. She was included by Stat News on their definitive list of leaders in the life sciences in 2022.

Freda Kathryn Stevenson is a British immunologist and Professor at the University of Southampton. She was elected a Fellow of the Academy of Medical Sciences in 2000, and was the first British researcher to be awarded the American Society of Hematology Henry M. Stratton Medal.

References

  1. ↑ "Margaret LIU - Dirigeant de la société Ipsen". BFMBusiness.com.
  2. 1 2 3 4 5 "Margaret A. Liu". International Society for Vaccines (ISV). Retrieved 1 May 2019.
  3. ↑ "Executive Profile* Margaret A. Liu Director, Ipsen S.A." Bloomberg. Retrieved 1 May 2019.
  4. ↑ "Ipsen nominates Dr Margaret Liu and Carol Stuckley for election to its Board as Independent Directors". Talent4Boards. April 25, 2017. Retrieved 1 May 2019.
  5. 1 2 Fynan, Ellen F.; Lu, Shan; Robinson, Harriet L. (September 2018). "One Group's Historical Reflections on DNA Vaccine Development". Human Gene Therapy. 29 (9): 966–970. doi:10.1089/hum.2018.066. PMC   6152846 . PMID   30129778. S2CID   52049152.
  6. 1 2 3 "Two new honorary doctors at Karolinska Institutet 2017". Karolinska Institutet News. 2017-03-29. Retrieved 1 May 2019.
  7. ↑ Liu, M. A. (April 2003). "DNA vaccines: a review". Journal of Internal Medicine. 253 (4): 402–410. doi: 10.1046/j.1365-2796.2003.01140.x . PMID   12653868. S2CID   4637418.
  8. ↑ Griscom, Amanda (September 1, 2002). "Take These Genes and Call Me in the Morning". Wired. Retrieved 1 May 2019.
  9. ↑ Liu, Margaret A; Rees, Jenaid (4 December 2014). "An interview with Margaret A Liu: the future of gene-based vaccines and immunotherapies, and other musings". Expert Review of Vaccines. 14 (2): 157–159. doi: 10.1586/14760584.2015.988145 . PMID   25474286.
  10. ↑ Liu, M. A. (24 April 2019). "A Comparison of Plasmid DNA and mRNA as Vaccine Technologies". Vaccines. 7 (2): 37. doi: 10.3390/vaccines7020037 . PMC   6631684 . PMID   31022829. S2CID   133604074.
  11. 1 2 3 Svitil, Kathy (13 November 2002). "The 50 Most Important Women in Science". Discover. Retrieved 1 May 2019.
  12. 1 2 3 4 5 6 Liu, Margaret Ann (2019-05-04). "From the wild west to the frontiers of immunology: the journey of a Chinese-American scientist". Human Vaccines & Immunotherapeutics. 15 (5): 1016–1020. doi:10.1080/21645515.2019.1597583. ISSN   2164-5515. PMC   6628870 . PMID   30942654. S2CID   92999808.
  13. ↑ "Durango native Margaret Liu is 'The Mother of DNA Vaccines'". The Washington Times. Retrieved 2020-01-29.
  14. ↑ Butler, Ann (March 14, 2015). "Durango native Margaret Liu is 'The Mother of DNA Vaccines'". The Washington Times. Retrieved 1 May 2019.
  15. 1 2 3 "ISV - International Society for Vaccines (Congress, Member, Membership)". www.isv-online.org. Retrieved 2020-01-29.
  16. 1 2 Marantz Henig, Robin (March 30, 1993). "New Vaccine Method Using DNA Protects Mice Against a Flu Virus". The New York Times. Retrieved 1 May 2019.
  17. ↑ Watanabe, Myrna (September 28, 1998). "In Search of an HIV Vaccine: Meet the Researchers 'Standing On Each Others' Shoulders'". The Scientist. Retrieved 1 May 2019.
  18. ↑ "Chiron Announces Dr. Liu to Head U.S. Vaccines Research". Jon Cohen AIDS Research Collection, University of Michigan. Retrieved 1 May 2019.
  19. ↑ "Ipsen nominates Dr Margaret Liu and Carol Stuckley for election to its Board as Independent Directors". Talent4Boards. 2017-04-25. Retrieved 2020-01-29.
  20. ↑ Fuller, Jacquelline. "Dr. Margaret Liu to join the Global Health program at the Bill & Melinda Gates Foundation". Bill & Melinda Gates Foundation. Retrieved 1 May 2019.
  21. ↑ "Dr. Margaret Liu to join the Global Health program at the Bill & Melinda Gates Foundation". Bill & Melinda Gates Foundation. Retrieved 2020-01-29.
  22. ↑ "Five Join NIAID Advisory Council". The NIH Record. LIV (4). February 19, 2002. Retrieved 1 May 2019.
  23. ↑ Chiron (Firm) (2008). Chiron Announces Dr. Liu to Head U.S. Vaccines Research.
  24. ↑ Lambert, Paul-Henri; Liu, Margaret; Siegrist, Claire-Anne (5 April 2005). "Can successful vaccines teach us how to induce efficient protective immune responses?". Nature Medicine. 11 (S4): S54–S62. doi: 10.1038/nm1216 . PMID   15812491. S2CID   11685892.
  25. ↑ Kutzler, Michele A.; Weiner, David B. (October 2008). "DNA vaccines: ready for prime time?". Nature Reviews Genetics. 9 (10): 776–788. doi:10.1038/nrg2432. PMC   4317294 . PMID   18781156. S2CID   22546925.
This page is based on this Wikipedia article
Text is available under the CC BY-SA 4.0 license; additional terms may apply.
Images, videos and audio are available under their respective licenses.